Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             30 results found
no title author magazine year volume issue page(s) type
1 Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With Chemoradiotherapy Damhuis, Ronald

25 8 p. 683-689
article
2 Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer Meyer, May-Lucie

25 8 p. e482-e486.e3
article
3 Comments on “Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma” Huang, Jie

25 8 p. e446-e447
article
4 Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations Lara, Matthew S.

25 8 p. 732-737
article
5 DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer Bestvina, Christine M.

25 8 p. e448-e452
article
6 Editorial Board
25 8 p. A1
article
7 Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM) Enrico, Diego

25 8 p. 723-731.e2
article
8 Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging Liu, Jianjiang

25 8 p. 690-698.e2
article
9 Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring STK11 Genetic Aberration: A Protocol of Phase II Study Jiang, Huixin

25 8 p. e393-e396
article
10 Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients Jha, Prerana

25 8 p. e420-e430.e20
article
11 Letter to the Editor in Response to “Adherence to Annual Lung Cancer Screening in a Centralized Academic Program” Wu, Julie

25 8 p. e457-e458
article
12 Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC Leonetti, Alessandro

25 8 p. e436-e445.e9
article
13 Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition Acker, Fabian

25 8 p. 672-682.e5
article
14 Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies Smith, Margaret R.

25 8 p. e379-e388
article
15 Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk Chen, Olivia H.

25 8 p. 738-743.e2
article
16 Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy Huet, C.

25 8 p. e402-e410.e3
article
17 Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer: The Time is Coming Avancini, Alice

25 8 p. e431-e435
article
18 RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer Reyes, Amanda

25 8 p. e411-e419
article
19 Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study Kakiuchi, Yosuke

25 8 p. 661-671.e7
article
20 Response to Editor: Commentary on “Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma” Chen, Qin

25 8 p. e479-e481
article
21 Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage Ⅳ Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN Study Ma, Jia

25 8 p. e389-e392
article
22 Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study Graber-Naidich, Anna

25 8 p. 705-711.e7
article
23 Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator Tissera, Sanuki

25 8 p. e466-e478
article
24 Table of Contents
25 8 p. A3-A7
article
25 The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment Bennati, Chiara

25 8 p. e397-e401
article
26 Understanding the Social Risk Factors That Avert Equitable Lung Cancer Care Kapp, Christopher M.

25 8 p. 699-704
article
27 Untapping the Prognostic Value of Patient-Generated Health Data in Locally Advanced Non-small Cell Lung Cancer Ohri, Nitin

25 8 p. e459-e465.e1
article
28 Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer Watson, Alexander S.

25 8 p. 712-722.e1
article
29 Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Population: A Multicenter Retrospective Cohort Study Qasim, Rameez

25 8 p. e453-e454
article
30 “Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Population: A Multicenter Retrospective Cohort Study” Pan, Hanbo

25 8 p. e455-e456
article
                             30 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands